News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Nov 01, 2018DxTerity will present on Thursday, November 15, 2018 at 11:30 a.m. PT (2:30 p.m. ET) in New York
Los Angeles, CA, November 1, 2018 – DxTerity, a molecular information and diagnostics company developing at-home RNA monitoring blood tests for immune-mediated diseases, today announced that...
- Oct 21, 2018Autoimmune Profile Test (AIP) shows promise for stratifying patients based on Type I interferon expression levels
Los Angeles, CA, October 21, 2018 – DxTerity, a molecular information and diagnostics company developing at-home RNA monitoring blood tests for immune-mediated diseases, today announced that...
- Sep 24, 2018
DxTerity CEO & Founder Bob Terbrueggen will be speaking at two upcoming conferences in October: World CB & CDx in Boston, MA and Precision Medicine in Autoimmunity in Denver, CO. Dr. Terbrueggen...
- Sep 19, 2018Total revenues of approximately $6.8 million for the second quarter of 2018 compared to $6.1 million for the second quarter of 2017.
Dallas, TX, August 10, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2018 financial...
- Aug 31, 2018
Los Angeles, CA – PM360, a publication for marketing decision markers in the pharmaceutical, biotech, and medical device industries, recently named DxTerity’s EMPOWER Study Recruitment as a...